KNSA: SEC Form 144 filed by Kiniksa Pharmaceuticals International plc
Stocks in this Quantisnow insightHealth Care
Full content unavailable. See the original source below.
Historical context for KNSA
Across the 20 sessions after earlier KNSA headlines, the stock closed higher 9 times and lower 11 times, with a median move of 1.7% in either direction. This shows timing only: many things move a stock in a session, and these figures do not show that any headline caused a move.
| Session | Earlier headline | KNSA | SPY |
|---|---|---|---|
| Oct 27, 2026 | Kiniksa Pharmaceuticals Reports Third Quarter 2026 Financial Results and Recent Portfolio Execution | +22.2% | +0.6% |
| Oct 23, 2026 | Kiniksa Pharmaceuticals to Report Third Quarter 2026 Financial Results on October 27, 2026 | -5.0% | -0.5% |
| Sep 30, 2026 | Wells Fargo initiated coverage on Kiniksa Pharmaceuticals with a new price target | -1.5% | -0.2% |
| Sep 8, 2026 | Kiniksa Pharmaceuticals to Present at Wells Fargo 21st Annual Healthcare Conference | -1.1% | -0.5% |
| Aug 10, 2026 | Kiniksa Pharmaceuticals to Present at Canaccord Genuity 46th Annual Growth Conference | +0.6% | -0.0% |
| Jul 28, 2026 | Kiniksa Pharmaceuticals Reports Second Quarter 2026 Financial Results and Recent Portfolio Execution | +25.0% | +0.2% |
Quantisnow market dataNASDAQ
KNSA
Kiniksa Pharmaceuticals International plc
- Market cap
- 30-day
- Sector
- Health Care
- Industry
- Biotechnology: Pharmaceutical Preparations
- Listed since
- 2018
Get push alerts for KNSA
Full KNSA profile on Quantisnow Follow KNSA and get a push notification the moment its next story breaks.
Original source Picked up and delivered by Quantisnow in real time